1
1 Laboratoire de Chimie des Polymères Organiques - Pessac - France CNRS UMR5629 - Université Bordeaux 1- Institut Polytechnique de Bordeaux 2 Department of Chemical Engineering, Waterloo Institute of Nanotechnology, University of Waterloo, Waterloo, Canada INTRODUCTION Drug delivery system Correspondants: [email protected], [email protected] Acknowledgements: Université Bordeaux 1, Conseil régional d’Aquitaine, IDS-FunMat, IPB-ENSBP for their financial support Ring opening polymerisation Organic N-Heterocyclic carbene catalyst eliminates traditional meta l catalysts and metallic by products Good control,accurate targeting of DPs Functionalisation of PTMC block via UV- initiated thiol-ene “click” chemistry Fast reaction time, ambient conditions Ring opening polymerisation utilizing a macromolecular initiator PTMC DP target DP Expt PDI 13 12 1.07 30 29 1.09 50 46 1.05 Functionalized PTMC CHCl 2 , 48 h TFA/HBr Via Nanoprecipitation Model Chemistry Enzyme-Responsive Trigger (In Progress) In the presence of MMP enzymes, peptide is cleaved and drug released MMP 2, 9 Synthetic peptide can be specifically cleaved by MMP 2, 9 enzymes found almost exclusively in tumour microenvironments A - P - V - G - L - I - G - A - C Macromolecular coupling via thiol- ene “click” chemistry Optimal conditions under review Ring opening polymerisation utilizing a macromolecular initiator Procaine Selective Electrode Electrode Validation ~200 nm Traditional methods of drug quantification suffer from a number of inaccuracies Drug-selective membranes can be synthesized and used for direct electro-chemical measurements of drug concentrations Future Work Current cancer therapies suffer from a lack of specificity Therapeutics damage both diseased and healthy cells Aim to exploit the unique enzymatic environment of tumour cells for a targeted and triggered delivery system Polymersomes based on PTMC-b-PGA coploymer a) Schematic of double barrier effect. b) changes in drug release profiles due to changes in dialysis bag MWCO Quantifying drug release by dialysis suffers from double-barrier effect and inaccuracies due to dialysis membrane interference Procaine-Selective Membrane Drug/PVC Plasticizer NaTPS 50 % 49 % 1 % y = 12.706ln(x) + 181.63 R² = 0.9857 50 100 150 0.0004 0.04 Voltage (mV) Procaine Concentration (mol/L) Quantifying drug concentrations a) Electrode response over a range of concentrations. b) Electrode response over 24 h. Live monitoring of drug loading and release from polymersomes using drug-selective electrodes Development of electrodes responsive to various other drugs Assembly of polymersomes from PTMC-peptide-PGA system and loading of drugs Measurements of burst release in the presence of MMP-2,9 Daniel Bacinello 1, 2 , Michael Tam 2 , Daniel Taton 1 , Sébastien Lecommandoux 1 LCPO a) Schematic of electrode b) Schematic of electro- chemical cell a b c a b 0 50 100 150 0.0 10.0 20.0 30.0 Voltage (mV) Time (h) c) Procaine-selective membrane composition Probe shows logarithmic response over a range of drug concentrations and drift of 0.3 mV/h over a 24 h period a b IPR 2012

LCPO - Home | University of Waterloo | University of Waterloo · 1Laboratoire de Chimie des Polymères Organiques - Pessac - France CNRS UMR5629 - Université Bordeaux 1- Institut

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: LCPO - Home | University of Waterloo | University of Waterloo · 1Laboratoire de Chimie des Polymères Organiques - Pessac - France CNRS UMR5629 - Université Bordeaux 1- Institut

1Laboratoire de Chimie des Polymères Organiques - Pessac - France

CNRS UMR5629 - Université Bordeaux 1- Institut Polytechnique de Bordeaux 2Department of Chemical Engineering, Waterloo Institute of Nanotechnology,

University of Waterloo, Waterloo, Canada

INTRODUCTION – Drug delivery system

•Correspondants: [email protected], [email protected] Acknowledgements: Université Bordeaux 1, Conseil régional d’Aquitaine, IDS-FunMat, IPB-ENSBP for their financial support

•Ring opening polymerisation •Organic N-Heterocyclic carbene catalyst eliminates traditional meta l catalysts and metallic by products •Good control,accurate targeting of DPs

• Functionalisation of PTMC block via UV-initiated thiol-ene “click” chemistry •Fast reaction time, ambient conditions

• Ring opening polymerisation utilizing a macromolecular initiator

PTMC

DPtarget DPExpt PDI

13 12 1.07

30 29 1.09

50 46 1.05

Functionalized PTMC

CHCl2, 48 h

TFA/HBr

Via Nanoprecipitation

Model Chemistry

Enzyme-Responsive Trigger (In Progress) • In the presence of MMP enzymes, peptide is cleaved and drug released

MMP 2, 9 •Synthetic peptide can be specifically cleaved by MMP 2, 9 enzymes found almost exclusively in tumour microenvironments

A - P - V - G - L - I - G - A - C

• Macromolecular coupling via thiol-ene “click” chemistry •Optimal conditions under review

•Ring opening polymerisation utilizing a macromolecular initiator

Procaine Selective Electrode

Electrode Validation

~200 nm

• Traditional methods of drug quantification suffer from a number of inaccuracies • Drug-selective membranes can be synthesized and used for direct electro-chemical measurements of drug concentrations

Future Work

• Current cancer therapies suffer from a lack of specificity •Therapeutics damage both diseased and healthy cells •Aim to exploit the unique enzymatic environment of tumour cells for a targeted and triggered delivery system •Polymersomes based on PTMC-b-PGA coploymer

a) Schematic of double barrier effect. b) changes in drug release profiles due to changes in dialysis bag MWCO

•Quantifying drug release by dialysis suffers from double-barrier effect and inaccuracies due to dialysis membrane interference

Procaine-Selective Membrane

Drug/PVC Plasticizer NaTPS

50 % 49 % 1 %

y = 12.706ln(x) + 181.63 R² = 0.9857

50

100

150

0.0004 0.04

Vo

ltag

e (m

V)

Procaine Concentration (mol/L)

Quantifying drug concentrations

a) Electrode response over a range of concentrations. b) Electrode response over 24 h.

• Live monitoring of drug loading and release from polymersomes using drug-selective electrodes •Development of electrodes responsive to various other drugs

•Assembly of polymersomes from PTMC-peptide-PGA system and loading of drugs •Measurements of burst release in the presence of MMP-2,9

Daniel Bacinello1, 2, Michael Tam2, Daniel Taton1, Sébastien Lecommandoux1

LCPO

a) Schematic of electrode b) Schematic of electro-

chemical cell

a b c

a b

0

50

100

150

0.0 10.0 20.0 30.0

Vo

ltag

e (m

V)

Time (h)

c) Procaine-selective membrane composition

•Probe shows logarithmic response over a range of drug concentrations and drift of 0.3 mV/h over a 24 h period

a b IPR 20

12